[Genetic changes and clinical management in familial hypertrophic cardiomyopathy]
- PMID: 10806915
[Genetic changes and clinical management in familial hypertrophic cardiomyopathy]
Abstract
Hypertrophic cardiomyopathy (HCM) is phenotypically and genotypically heterogeneous disease of heart. Nine chromosomal loci responsible for this condition have been identified: beta-myosin heavy chain, essential and regulatory myosin light chains, troponin T and I subunits, alpha-tropomosin, cardiac myosin binding protein C, cardiac actin and titin. These genes code for proteins involved in the contraction mechanism or in the control of contraction, therefore HCM has been classified as a disease of cardiac sarcomere. Over 107 mutations have been identified. More then half of them have been detected in the beta-myosin heavy chain gene (beta-MHC). Some mutations in beta-MHC gene are associated with a benign prognosis, other are associated with high incidence of sudden cardiac death (SCD) and severe hypertrophy. Mutations in myosin binding protein C are associated with mild, delayed expression of cardiac hypertrophy and benign prognosis. Mutations in cardiac troponinT are associated with a mild degree of hypertrophy but a high incidence of SCD. Study of genes responsible for HCM will assume role in the context of clinical management of HCM, in particular regarding diagnosis and prognosis patients and families with HCM.
Similar articles
-
[Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review].Invest Clin. 2004 Mar;45(1):69-99. Invest Clin. 2004. PMID: 15058760 Review. Spanish.
-
Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.Ann Med. 1998 Aug;30 Suppl 1:24-32. Ann Med. 1998. PMID: 9800880 Review.
-
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.J Cardiovasc Med (Hagerstown). 2006 Aug;7(8):601-7. doi: 10.2459/01.JCM.0000237908.26377.d6. J Cardiovasc Med (Hagerstown). 2006. PMID: 16858239
-
Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.J Investig Med. 1997 Apr;45(4):191-6. J Investig Med. 1997. PMID: 9154300
-
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.J Am Coll Cardiol. 2004 Nov 2;44(9):1903-10. doi: 10.1016/j.jacc.2004.07.045. J Am Coll Cardiol. 2004. PMID: 15519027
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials